Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rantamäki T[au]:

P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy. Neyazi A et al. Transl Psychiatry. (2018)

Isoflurane produces antidepressant effects and induces TrkB signaling in rodents. Antila H et al. Sci Rep. (2017)

Depression and antidepressant action-from molecules to networks. Rantamäki T et al. Cell Tissue Res. (2019)

Search results

Items: 1 to 50 of 65

1.

Encoding, Consolidation, and Renormalization in Depression: Synaptic Homeostasis, Plasticity, and Sleep Integrate Rapid Antidepressant Effects.

Rantamäki T, Kohtala S.

Pharmacol Rev. 2020 Apr;72(2):439-465. doi: 10.1124/pr.119.018697. Review.

PMID:
32139613
2.

Ketamine induces rapid and sustained antidepressant-like effects in chronic pain induced depression: Role of MAPK signaling pathway.

Humo M, Ayazgök B, Becker LJ, Waltisperger E, Rantamäki T, Yalcin I.

Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jun 8;100:109898. doi: 10.1016/j.pnpbp.2020.109898. Epub 2020 Feb 25.

PMID:
32109506
3.

Digital autoradiography for efficient functional imaging without anesthesia in experimental animals: Reversing phencyclidine-induced functional alterations using clozapine.

Alitalo O, Rantamäki T, Huhtala T.

Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jun 8;100:109887. doi: 10.1016/j.pnpbp.2020.109887. Epub 2020 Feb 12.

4.

Ketamine-induced regulation of TrkB-GSK3β signaling is accompanied by slow EEG oscillations and sedation but is independent of hydroxynorketamine metabolites.

Kohtala S, Theilmann W, Rosenholm M, Müller HK, Kiuru P, Wegener G, Yli-Kauhaluoma J, Rantamäki T.

Neuropharmacology. 2019 Oct;157:107684. doi: 10.1016/j.neuropharm.2019.107684. Epub 2019 Jun 25.

5.

Commentary: Commonly Used Anesthesia/Euthanasia Methods for Brain Collection Differentially Impact MAPK Activity in Male and Female C57BL/6 Mice.

Kohtala S, Rantamäki T.

Front Cell Neurosci. 2019 May 28;13:219. doi: 10.3389/fncel.2019.00219. eCollection 2019. No abstract available.

6.

Depression and antidepressant action-from molecules to networks.

Rantamäki T, Yalcin I.

Cell Tissue Res. 2019 Jul;377(1):1-4. doi: 10.1007/s00441-019-03042-6. No abstract available.

PMID:
31073906
7.

Sleep-State Dependent Alterations in Brain Functional Connectivity under Urethane Anesthesia in a Rat Model of Early-Stage Parkinson's Disease.

Zhurakovskaya E, Leikas J, Pirttimäki T, Casas Mon F, Gynther M, Aliev R, Rantamäki T, Tanila H, Forsberg MM, Gröhn O, Paasonen J, Jalkanen AJ.

eNeuro. 2019 Feb 26;6(1). pii: ENEURO.0456-18.2019. doi: 10.1523/ENEURO.0456-18.2019. eCollection 2019 Jan-Feb.

8.

Dual mechanism of TRKB activation by anandamide through CB1 and TRPV1 receptors.

Diniz CRAF, Biojone C, Joca SRL, Rantamäki T, Castrén E, Guimarães FS, Casarotto PC.

PeerJ. 2019 Feb 21;7:e6493. doi: 10.7717/peerj.6493. eCollection 2019.

9.

TrkB neurotrophin receptor at the core of antidepressant effects, but how?

Rantamäki T.

Cell Tissue Res. 2019 Jul;377(1):115-124. doi: 10.1007/s00441-018-02985-6. Epub 2019 Jan 12. Review.

PMID:
30637517
10.

Searching for ketamine's antidepressant mechanisms: From synaptic plasticity to dentate gyrus cell proliferation.

Rantamäki T.

Acta Physiol (Oxf). 2019 Apr;225(4):e13252. doi: 10.1111/apha.13252. Epub 2019 Jan 28. No abstract available.

PMID:
30635986
11.

Dyskinesia and brain-derived neurotrophic factor levels after long-term levodopa and nicotinic receptor agonist treatments in female mice with near-total unilateral dopaminergic denervation.

Leino S, Kohtala S, Rantamäki T, Koski SK, Rannanpää S, Salminen O.

BMC Neurosci. 2018 Nov 29;19(1):77. doi: 10.1186/s12868-018-0478-0.

12.

Dose-dependent effects of isoflurane on TrkB and GSK3β signaling: Importance of burst suppression pattern.

Theilmann W, Alitalo O, Yorke I, Rantamäki T.

Neurosci Lett. 2019 Feb 16;694:29-33. doi: 10.1016/j.neulet.2018.11.018. Epub 2018 Nov 15.

13.

Cortical Excitability and Activation of TrkB Signaling During Rebound Slow Oscillations Are Critical for Rapid Antidepressant Responses.

Kohtala S, Theilmann W, Rosenholm M, Penna L, Karabulut G, Uusitalo S, Järventausta K, Yli-Hankala A, Yalcin I, Matsui N, Wigren HK, Rantamäki T.

Mol Neurobiol. 2019 Jun;56(6):4163-4174. doi: 10.1007/s12035-018-1364-6. Epub 2018 Oct 4.

14.

P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy.

Neyazi A, Theilmann W, Brandt C, Rantamäki T, Matsui N, Rhein M, Kornhuber J, Bajbouj M, Sperling W, Bleich S, Frieling H, Löscher W.

Transl Psychiatry. 2018 Jan 22;8(1):25. doi: 10.1038/s41398-017-0077-3.

15.

Isoflurane produces antidepressant effects and induces TrkB signaling in rodents.

Antila H, Ryazantseva M, Popova D, Sipilä P, Guirado R, Kohtala S, Yalcin I, Lindholm J, Vesa L, Sato V, Cordeira J, Autio H, Kislin M, Rios M, Joca S, Casarotto P, Khiroug L, Lauri S, Taira T, Castrén E, Rantamäki T.

Sci Rep. 2017 Aug 10;7(1):7811. doi: 10.1038/s41598-017-08166-9.

16.

Brief isoflurane anesthesia regulates striatal AKT-GSK3β signaling and ameliorates motor deficits in a rat model of early-stage Parkinson's disease.

Leikas JV, Kohtala S, Theilmann W, Jalkanen AJ, Forsberg MM, Rantamäki T.

J Neurochem. 2017 Aug;142(3):456-463. doi: 10.1111/jnc.14066. Epub 2017 Jun 14.

17.

Repeated brief isoflurane anesthesia during early postnatal development produces negligible changes on adult behavior in male mice.

Rosenholm M, Paro E, Antila H, Võikar V, Rantamäki T.

PLoS One. 2017 Apr 5;12(4):e0175258. doi: 10.1371/journal.pone.0175258. eCollection 2017.

18.

Combined ipsilateral limb use score as an index of motor deficits and neurorestoration in parkinsonian rats.

Leikas JV, Kääriäinen TM, Jalkanen AJ, Lehtonen M, Rantamäki T, Forsberg MM.

J Neurosci Res. 2017 Sep;95(9):1858-1870. doi: 10.1002/jnr.24022. Epub 2017 Jan 30.

PMID:
28134996
19.

Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits.

Gerenu G, Martisova E, Ferrero H, Carracedo M, Rantamäki T, Ramirez MJ, Gil-Bea FJ.

Biochim Biophys Acta Mol Basis Dis. 2017 Apr;1863(4):991-1001. doi: 10.1016/j.bbadis.2017.01.023. Epub 2017 Jan 26.

20.

Brief Isoflurane Anesthesia Produces Prominent Phosphoproteomic Changes in the Adult Mouse Hippocampus.

Kohtala S, Theilmann W, Suomi T, Wigren HK, Porkka-Heiskanen T, Elo LL, Rokka A, Rantamäki T.

ACS Chem Neurosci. 2016 Jun 15;7(6):749-56. doi: 10.1021/acschemneuro.6b00002. Epub 2016 Apr 28.

PMID:
27074656
21.

NCAM-deficient mice show prominent abnormalities in serotonergic and BDNF systems in brain - Restoration by chronic amitriptyline.

Aonurm-Helm A, Anier K, Zharkovsky T, Castrén E, Rantamäki T, Stepanov V, Järv J, Zharkovsky A.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2394-403. doi: 10.1016/j.euroneuro.2015.10.001. Epub 2015 Oct 21.

PMID:
26499173
22.

Antidepressant drug action--From rapid changes on network function to network rewiring.

Rantamäki T, Yalcin I.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:285-92. doi: 10.1016/j.pnpbp.2015.06.001. Epub 2015 Jun 9. Review.

PMID:
26066070
23.

Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and neuroprotective signaling events in the mouse hippocampus and prefrontal cortex.

Koskimäki J, Matsui N, Umemori J, Rantamäki T, Castrén E.

Cell Mol Neurobiol. 2015 Mar;35(2):189-96. doi: 10.1007/s10571-014-0110-5. Epub 2014 Sep 10.

PMID:
25204460
24.

Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome.

Uutela M, Lindholm J, Rantamäki T, Umemori J, Hunter K, Võikar V, Castrén ML.

Front Cell Neurosci. 2014 May 28;8:150. doi: 10.3389/fncel.2014.00150. eCollection 2014.

25.

VGF (TLQP-62)-induced neurogenesis targets early phase neural progenitor cells in the adult hippocampus and requires glutamate and BDNF signaling.

Thakker-Varia S, Behnke J, Doobin D, Dalal V, Thakkar K, Khadim F, Wilson E, Palmieri A, Antila H, Rantamaki T, Alder J.

Stem Cell Res. 2014 May;12(3):762-77. doi: 10.1016/j.scr.2014.03.005. Epub 2014 Mar 26.

26.

Utilization of in situ ELISA method for examining Trk receptor phosphorylation in cultured cells.

Antila H, Autio H, Turunen L, Harju K, Tammela P, Wennerberg K, Yli-Kauhaluoma J, Huttunen HJ, Castrén E, Rantamäki T.

J Neurosci Methods. 2014 Jan 30;222:142-6. doi: 10.1016/j.jneumeth.2013.11.001. Epub 2013 Nov 12.

PMID:
24239780
27.

The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease.

Rantamäki T, Kemppainen S, Autio H, Stavén S, Koivisto H, Kojima M, Antila H, Miettinen PO, Kärkkäinen E, Karpova N, Vesa L, Lindemann L, Hoener MC, Tanila H, Castrén E.

PLoS One. 2013 Jul 3;8(7):e68722. doi: 10.1371/journal.pone.0068722. Print 2013.

28.

Sleep homeostasis and depression: studies with the rat clomipramine model of depression.

Savelyev SA, Rantamäki T, Rytkönen KM, Castren E, Porkka-Heiskanen T.

Neuroscience. 2012 Jun 14;212:149-58. doi: 10.1016/j.neuroscience.2012.03.029. Epub 2012 Apr 16.

PMID:
22516018
29.

The responsiveness of TrkB to BDNF and antidepressant drugs is differentially regulated during mouse development.

Di Lieto A, Rantamäki T, Vesa L, Yanpallewar S, Antila H, Lindholm J, Rios M, Tessarollo L, Castrén E.

PLoS One. 2012;7(3):e32869. doi: 10.1371/journal.pone.0032869. Epub 2012 Mar 2.

30.

Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice.

Kemppainen S, Rantamäki T, Jerónimo-Santos A, Lavasseur G, Autio H, Karpova N, Kärkkäinen E, Stavén S, Vicente Miranda H, Outeiro TF, Diógenes MJ, Laroche S, Davis S, Sebastião AM, Castrén E, Tanila H.

Neurobiol Aging. 2012 Jun;33(6):1122.e23-39. doi: 10.1016/j.neurobiolaging.2011.11.006. Epub 2011 Dec 30.

PMID:
22209410
31.

The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.

Lindholm JS, Autio H, Vesa L, Antila H, Lindemann L, Hoener MC, Skolnick P, Rantamäki T, Castrén E.

Neuropharmacology. 2012 Jan;62(1):391-7. doi: 10.1016/j.neuropharm.2011.08.015. Epub 2011 Aug 16.

PMID:
21867718
32.

Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus.

Autio H, Mätlik K, Rantamäki T, Lindemann L, Hoener MC, Chao M, Arumäe U, Castrén E.

Neuropharmacology. 2011 Dec;61(8):1291-6. doi: 10.1016/j.neuropharm.2011.07.033. Epub 2011 Jul 30.

33.

Antidepressant drugs transactivate TrkB neurotrophin receptors in the adult rodent brain independently of BDNF and monoamine transporter blockade.

Rantamäki T, Vesa L, Antila H, Di Lieto A, Tammela P, Schmitt A, Lesch KP, Rios M, Castrén E.

PLoS One. 2011;6(6):e20567. doi: 10.1371/journal.pone.0020567. Epub 2011 Jun 7.

34.

A role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress.

Razzoli M, Domenici E, Carboni L, Rantamaki T, Lindholm J, Castrén E, Arban R.

Genes Brain Behav. 2011 Jun;10(4):424-33. doi: 10.1111/j.1601-183X.2011.00681.x. Epub 2011 Feb 21.

35.

Alterations in BDNF and phospho-CREB levels following chronic oral nicotine treatment and its withdrawal in dopaminergic brain areas of mice.

Kivinummi T, Kaste K, Rantamäki T, Castrén E, Ahtee L.

Neurosci Lett. 2011 Mar 17;491(2):108-12. doi: 10.1016/j.neulet.2011.01.015. Epub 2011 Jan 11.

PMID:
21232579
36.

BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse.

Louhivuori V, Vicario A, Uutela M, Rantamäki T, Louhivuori LM, Castrén E, Tongiorgi E, Akerman KE, Castrén ML.

Neurobiol Dis. 2011 Feb;41(2):469-80. doi: 10.1016/j.nbd.2010.10.018. Epub 2010 Nov 1.

PMID:
21047554
37.

Effects of maternal smoking and exposure to methylmercury on brain-derived neurotrophic factor concentrations in umbilical cord serum.

Spulber S, Rantamäki T, Nikkilä O, Castrén E, Weihe P, Grandjean P, Ceccatelli S.

Toxicol Sci. 2010 Oct;117(2):263-9. doi: 10.1093/toxsci/kfq216. Epub 2010 Jul 14.

38.

Darkness reduces BDNF expression in the visual cortex and induces repressive chromatin remodeling at the BDNF gene in both hippocampus and visual cortex.

Karpova NN, Rantamäki T, Di Lieto A, Lindemann L, Hoener MC, Castrén E.

Cell Mol Neurobiol. 2010 Oct;30(7):1117-23. doi: 10.1007/s10571-010-9544-6. Epub 2010 Jul 8.

PMID:
20614233
39.

The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.

Castrén E, Rantamäki T.

Dev Neurobiol. 2010 Apr;70(5):289-97. doi: 10.1002/dneu.20758. Review.

40.

Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment.

Castrén E, Rantamäki T.

CNS Drugs. 2010 Jan;24(1):1-7. doi: 10.2165/11530010-000000000-00000. Review.

PMID:
20030415
41.

Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo.

Gyárfás T, Knuuttila J, Lindholm P, Rantamäki T, Castrén E.

Cell Mol Neurobiol. 2010 Apr;30(3):361-8. doi: 10.1007/s10571-009-9458-3. Epub 2009 Sep 24.

PMID:
19777340
42.

Brain-derived neurotrophic factor controls activity-dependent maturation of CA1 synapses by downregulating tonic activation of presynaptic kainate receptors.

Sallert M, Rantamäki T, Vesikansa A, Anthoni H, Harju K, Yli-Kauhaluoma J, Taira T, Castren E, Lauri SE.

J Neurosci. 2009 Sep 9;29(36):11294-303. doi: 10.1523/JNEUROSCI.0560-09.2009.

43.

A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility.

Bonetti A, Koivisto K, Pirttilä T, Elovaara I, Reunanen M, Laaksonen M, Ruutiainen J, Peltonen L, Rantamäki T, Tienari PJ.

J Neuroimmunol. 2009 Mar 31;208(1-2):119-24. doi: 10.1016/j.jneuroim.2009.01.003. Epub 2009 Feb 4.

44.

Neurotrophins in depression and antidepressant effects.

Castrén E, Rantamäki T.

Novartis Found Symp. 2008;289:43-52; discussion 53-9, 87-93. Review.

PMID:
18497094
45.

Targeting TrkB neurotrophin receptor to treat depression.

Rantamäki T, Castrén E.

Expert Opin Ther Targets. 2008 Jun;12(6):705-15. doi: 10.1517/14728222.12.6.705 . Review.

PMID:
18479217
46.

Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro.

Martin MG, Perga S, Trovò L, Rasola A, Holm P, Rantamäki T, Harkany T, Castrén E, Chiara F, Dotti CG.

Mol Biol Cell. 2008 May;19(5):2101-12. doi: 10.1091/mbc.E07-09-0897. Epub 2008 Feb 20.

47.
48.

Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain.

Rantamäki T, Hendolin P, Kankaanpää A, Mijatovic J, Piepponen P, Domenici E, Chao MV, Männistö PT, Castrén E.

Neuropsychopharmacology. 2007 Oct;32(10):2152-62. Epub 2007 Feb 21.

49.

Role of neurotrophic factors in depression.

Castrén E, Võikar V, Rantamäki T.

Curr Opin Pharmacol. 2007 Feb;7(1):18-21. Epub 2006 Oct 17. Review.

PMID:
17049922
50.

Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines.

Koponen E, Rantamäki T, Voikar V, Saarelainen T, MacDonald E, Castrén E.

Cell Mol Neurobiol. 2005 Sep;25(6):973-80.

PMID:
16392030

Supplemental Content

Loading ...
Support Center